Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening.

Kecerdasan mesin dalam terapeutika peptida: Perangkat generasi berikutnya untuk penapisan cepat penyakit.

Clicks: 440
ID: 101449
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #1 of 16 articles by views in medicinal research reviews

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Discovery and development of biopeptides are time-consuming, laborious, and dependent on various factors. Data-driven computational methods, especially machine learning (ML) approach, can rapidly and efficiently predict the utility of therapeutic peptides. ML methods offer an array of tools that can accelerate and enhance decision making and discovery for well-defined queries with ample and sophisticated data quality. Various ML approaches, such as support vector machines, random forest, extremely randomized tree, and more recently deep learning methods, are useful in peptide-based drug discovery. These approaches leverage the peptide data sets, created via high-throughput sequencing and computational methods, and enable the prediction of functional peptides with increased levels of accuracy. The use of ML approaches in the development of peptide-based therapeutics is relatively recent; however, these techniques are already revolutionizing protein research by unraveling their novel therapeutic peptide functions. In this review, we discuss several ML-based state-of-the-art peptide-prediction tools and compare these methods in terms of their algorithms, feature encodings, prediction scores, evaluation methodologies, and software utilities. We also assessed the prediction performance of these methods using well-constructed independent data sets. In addition, we discuss the common pitfalls and challenges of using ML approaches for peptide therapeutics. Overall, we show that using ML models in peptide research can streamline the development of targeted peptide therapies.
Penemuan dan pengembangan biopeptida memakan waktu, memerlukan banyak tenaga, dan bergantung pada berbagai faktor. Metode komputasi berbasis data, khususnya pendekatan pembelajaran mesin (*machine learning* atau ML), dapat memprediksi kegunaan peptida terapeutik secara cepat dan efisien. Metode ML menawarkan serangkaian instrumen yang dapat mempercepat dan meningkatkan pengambilan keputusan serta penemuan untuk kueri yang terdefinisi dengan baik dengan kualitas data yang memadai dan kompleks. Berbagai pendekatan ML, seperti *support vector machine*, *random forest*, *extremely randomized tree*, dan yang lebih baru metode *deep learning*, bermanfaat dalam penemuan obat berbasis peptida. Pendekatan-pendekatan ini memanfaatkan set data peptida, yang dihasilkan melalui sekuensing *high-throughput* dan metode komputasi, serta memungkinkan prediksi peptida fungsional dengan tingkat akurasi yang lebih tinggi. Penggunaan pendekatan ML dalam pengembangan agen terapeutik berbasis peptida tergolong relatif baru; kendati demikian, teknik-teknik ini telah merevolusi penelitian protein dengan mengungkap fungsi-fungsi baru dari peptida terapeutik. Dalam tinjauan ini, kami membahas beberapa instrumen prediksi peptida mutakhir berbasis ML dan membandingkan metode-metode tersebut dari segi algoritma, penyandian fitur, skor prediksi, metodologi evaluasi, dan utilitas perangkat lunak. Kami juga menilai performa prediksi metode-metode ini menggunakan set data independen yang dirancang dengan baik. Selain itu, kami membahas berbagai kendala umum dan tantangan dalam penggunaan pendekatan ML untuk pengembangan terapi peptida. Secara keseluruhan, kami menunjukkan bahwa penerapan model ML dalam penelitian peptida dapat merampingkan pengembangan terapi peptida terarah.
Reference Key
basith2020machinemedicinal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Basith, Shaherin;Manavalan, Balachandran;Hwan Shin, Tae;Lee, Gwang;
Journal medicinal research reviews
Year 2020
DOI
10.1002/med.21658
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.